Title:
ANTIGIARDIAL AGENT
Document Type and Number:
WIPO Patent Application WO/2016/194024
Kind Code:
A1
Abstract:
The present invention aims to provide an agent for the treatment of giardiasis. Provided is an antigiardial agent that includes a compound represented by general formula (1) and/or a salt thereof. The antigiardial agent is preferably for the treatment of infection with giardia, which parasites inside intestines, and the compound represented by general formula (1) and/or the salt thereof are preferably grounded. The grounded compound and/or the salt thereof preferably have an average particle size of from 1 to 1000 μm. General Formula (1) (In the formula, R1 and R2 each independently represent a hydrogen atom or a halogen atom, provided that at least one of R1 and R2 is a halogen atom.)
More Like This:
| JPWO2005089716 | High content formulation |
| WO/2006/109048 | NEW TRICYCLIC ANGIOTENSIN II AGONISTS |
| WO/2000/061576 | TRIARYLIMIDAZOLES |
Inventors:
MASUDA TAKAAKI (JP)
MIYATA YOSHIYUKI (JP)
MIYATA YOSHIYUKI (JP)
Application Number:
PCT/JP2015/004847
Publication Date:
December 08, 2016
Filing Date:
September 24, 2015
Export Citation:
Assignee:
POLA PHARMA INC (JP)
NIHON NOHYAKU CO LTD (JP)
NIHON NOHYAKU CO LTD (JP)
International Classes:
A61K31/4178; A61P33/02
Domestic Patent References:
| WO2012147584A1 | 2012-11-01 | |||
| WO2014115487A1 | 2014-07-31 |
Other References:
JEFFREY D KISER: "What's the most effective treatment for giardiasis?", CLINICAL INQUIRIES, 1 April 2008 (2008-04-01), pages 270 - 272, XP055248102, Retrieved from the Internet [retrieved on 20160205]
Attorney, Agent or Firm:
KAWAGUCHI, Yoshiyuki et al. (4-10 Higashi Nihonbashi 3-chome, Chuo-k, Tokyo 04, JP)
Download PDF: